140 related articles for article (PubMed ID: 20954315)
1. [Influence of lymphocitic thyroiditis on prognostic outcome differentiated thyroid carcinoma].
Filipović A; Paunović I; Vucković Lj
Acta Chir Iugosl; 2010; 57(2):85-94. PubMed ID: 20954315
[TBL] [Abstract][Full Text] [Related]
2. CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer.
Cunha LL; Marcello MA; Nonogaki S; Morari EC; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2015 Aug; 83(2):246-53. PubMed ID: 25130519
[TBL] [Abstract][Full Text] [Related]
3. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma.
Loh KC; Greenspan FS; Dong F; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1999 Feb; 84(2):458-63. PubMed ID: 10022401
[TBL] [Abstract][Full Text] [Related]
4. Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis.
Borowczyk M; Janicki A; Dworacki G; Szczepanek-Parulska E; Danieluk M; Barnett J; Antonik M; Kałużna M; Bromińska B; Czepczyński R; Bączyk M; Ziemnicka K; Ruchała M
J Endocrinol Invest; 2019 Jan; 42(1):45-52. PubMed ID: 29619749
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy.
Carvalho MS; Rosario PW; Mourão GF; Calsolari MR
Endocrine; 2017 Mar; 55(3):954-958. PubMed ID: 27878772
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents.
Iliadou PK; Effraimidis G; Konstantinos M; Grigorios P; Mitsakis P; Patakiouta F; Pazaitou-Panayiotou K
Eur J Endocrinol; 2015 Dec; 173(6):827-33. PubMed ID: 26369577
[TBL] [Abstract][Full Text] [Related]
8. Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma.
Cunha LL; Morari EC; Guihen AC; Razolli D; Gerhard R; Nonogaki S; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2012 Dec; 77(6):918-25. PubMed ID: 22738343
[TBL] [Abstract][Full Text] [Related]
9. [Does chronic lymphocytic thyroiditis influence the staging of differentiated thyroid carcinoma?].
Nemetz MA; Thomazelli FC; Granero LC; Nemetz AB; Dos Santos MB
Braz J Otorhinolaryngol; 2011; 77(1):77-83. PubMed ID: 21340193
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid carcinomas associated with chronic thyroiditis: biological and clinical properties.
Myshunina TM; Guda BD; Bolgov MY; Mikhailenko NI; Tronko ND
Exp Oncol; 2018 Jun; 40(2):128-131. PubMed ID: 29949530
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.
Jeong JS; Kim HK; Lee CR; Park S; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
J Korean Med Sci; 2012 Aug; 27(8):883-9. PubMed ID: 22876054
[TBL] [Abstract][Full Text] [Related]
13. Pediatric differentiated thyroid carcinoma: The clinicopathological features and the coexistence of Hashimoto's thyroiditis.
Ren PY; Liu J; Xue S; Chen G
Asian J Surg; 2019 Jan; 42(1):112-119. PubMed ID: 29254871
[TBL] [Abstract][Full Text] [Related]
14. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
[TBL] [Abstract][Full Text] [Related]
15. [Lymphocytic infiltration in thyroid neoplasms. Preliminary prognostic assessments].
Mancini A; Rabitti C; Conte G; Gullotta G; De Marinis L
Minerva Chir; 1993 Nov; 48(21-22):1283-8. PubMed ID: 8152558
[TBL] [Abstract][Full Text] [Related]
16. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland.
Matsubayashi S; Kawai K; Matsumoto Y; Mukuta T; Morita T; Hirai K; Matsuzuka F; Kakudoh K; Kuma K; Tamai H
J Clin Endocrinol Metab; 1995 Dec; 80(12):3421-4. PubMed ID: 8530576
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of thyroid lymphocytic infiltration in patients with medullary thyroid carcinoma.
Scopsi L; Collini P; Sampietro G; Boracchi P; Pilotti S
Thyroid; 1996 Dec; 6(6):613-7. PubMed ID: 9001197
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
[TBL] [Abstract][Full Text] [Related]
20. Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy.
Côrtes MCS; Rosario PW; Mourão GF; Calsolari MR
Braz J Otorhinolaryngol; 2018; 84(4):448-452. PubMed ID: 28625809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]